Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33)

קרןNational Institute of Neurological Disorders and Stroke/NIH
מדינהU.S.A.
סוגResearch Grants
תאריך אחרון17/10/2018
תאריכים נוספים20/02/2019
19/06/2019
17/10/2019
19/02/2020
17/06/2020
20/10/2020
17/02/2021
פקולטהLife Sciences, Medicine
תיאור

This grant provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological disorders that fall under the NINDS mission.

 

Funding: $750,000 total 

Duration: 3 years 

 

Research Authority due date: 10 days prior to submission

LOI (encouraged) due dates: 19.5.18, 17.9.18, 20.1.19, 19.5.19, 17.9.19, 19.1.20, 17.5.20, 20.9.20, 17.1.21

Full proposal due dates: 19.6.18, 17.10.18, 20.2.19, 19.6.19, 17.10.19, 19.2.20, 17.6.20, 20.10.20, 17.2.21

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 23/04/2018
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive